glycyrrhizic acid has been researched along with Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L | 1 |
| Cai, J; Deng, Y; Huang, H; Li, G; Luo, S; Lv, X; Zhang, Q; Zhao, B | 1 |
| Waki, K; Yamada, A | 1 |
| Gnanasekar, M; Ramaswamy, K; Thirugnanam, S; Xu, L | 1 |
| Cheng, XL; Cui, XB; Li, P; Peng, GP; Peng, YB; Qi, LW; Ren, MT; Zheng, YF | 1 |
| HUDSON, PB; MANN, P; MITTELMAN, A | 1 |
| Nixon, DW; Wang, ZY | 1 |
2 review(s) available for glycyrrhizic acid and Neoplasms
| Article | Year |
|---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction | 2015 |
Licorice and cancer.
Topics: Anticarcinogenic Agents; DNA Damage; Flavonoids; Flavoring Agents; Glycyrrhiza; Glycyrrhizic Acid; Humans; Kinetics; Neoplasms; Phenols; Phytotherapy; Polymers; Polyphenols; Safety; Treatment Outcome | 2001 |
5 other study(ies) available for glycyrrhizic acid and Neoplasms
| Article | Year |
|---|---|
Formulation of injectable glycyrrhizic acid-hydroxycamptothecin micelles as new generation of DNA topoisomerase I inhibitor for enhanced antitumor activity.
Topics: Administration, Intravenous; Animals; Camptothecin; Cell Proliferation; Drug Carriers; Drug Stability; Glycyrrhizic Acid; Hep G2 Cells; Humans; Male; Mice; Micelles; Neoplasms; Particle Size; Solubility; Topoisomerase I Inhibitors; Toxicity Tests; Xenograft Model Antitumor Assays | 2019 |
Blockade of high mobility group box 1 augments antitumor T-cell response induced by peptide vaccination as a co-adjuvant.
Topics: Adjuvants, Immunologic; Animals; Antigens; Cancer Vaccines; Cell Line, Tumor; Disease Models, Animal; Female; Gene Expression Regulation, Neoplastic; Glycyrrhizic Acid; HMGB1 Protein; Humans; Immunization; Lymphocyte Activation; Mice; Neoplasms; T-Lymphocyte Subsets; T-Lymphocytes; Vaccines, Subunit | 2016 |
Glycyrrhizin induces apoptosis in prostate cancer cell lines DU-145 and LNCaP.
Topics: Anti-Inflammatory Agents; Apoptosis; Caspases; Cell Line, Tumor; Cell Survival; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Electrophoresis, Agar Gel; Glycyrrhizic Acid; Humans; Male; Models, Chemical; Neoplasms; Time Factors | 2008 |
Oleanane-type triterpene glucuronides from the roots of Glycyrrhiza uralensis Fischer.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Female; Glycyrrhiza; Glycyrrhizic Acid; HeLa Cells; Humans; Molecular Structure; Neoplasms; Phytotherapy; Plant Extracts; Plant Roots; Saponins; Structure-Activity Relationship | 2010 |
Urinary steroid excretion after total adrenalectomy. I. Levels of 17-ketosteroids in cancer patients maintained on varying amounts of cortisone acetate and glycyrrhizin.
Topics: 17-Ketosteroids; Adrenal Glands; Adrenalectomy; Cortisone; Endocrine Glands; Glycyrrhiza; Glycyrrhizic Acid; Neoplasms; Steroids; Urine | 1953 |